KELOWNA, BC / ACCESSWIRE / June 28, 2022 / Avant Brands Inc. (TSX:AVNT) (OTCQX:AVTBF) (FRA:1BU0) (“Avant” or the “Company“), an award-winning leading producer of handcrafted, high quality cannabis products, announced today that it intends to release its financial and operating results for the second quarter ended May 31, 2022, after the close of the Toronto Stock Exchange on Wednesday, July 13, 2022.
A conference call with management will be held on Thursday, July 14, 2022, at 1 PM PT (4 PM ET).
Conference Call Dial Details
Canada/USA TF: +1-800-319-4610
International Toll: +1-604-638-5340
A transcript of the call will be posted on the Company’s website at www.avantbrands.ca within 48 hours of the call.
About Avant Brands Inc.
Avant is an innovative, market-leading cannabis company. Avant has multiple licensed and operational production facilities across Canada, which produce high-quality, handcrafted cannabis products for our highly desired and award-winning consumer brands, sold across both recreational and medical channels.
Avant’s recreational consumer brands include BLK MKT™, Tenzo™, Cognōscente™ and Treehugger™, all produced from rare and exceptional cultivars, and sold in British Columbia, Ontario, Saskatchewan, Manitoba, New Brunswick, and Yukon. The Company’s medical cannabis brand, GreenTec™, is distributed nationwide, directly to qualified patients through its GreenTec Medical portal, and through various medical cannabis partners.
Avant is a publicly traded corporation listed on the Toronto Stock Exchange (TSX: AVNT), and cross-trades on the OTCQX Best Market (OTCQX: AVTBF) and Frankfurt Stock Exchange (FRA: 1BU0). The Company is headquartered in Kelowna, British Columbia and has operations in British Columbia, Alberta and Ontario.
To learn more about Avant, to access the investor presentation, or learn more about its consumer brands, please visit www.avantbrands.ca.
Contact
Avant Brands Inc.
1-800-351-6358
ir@avantbrands.ca
SOURCE: Avant Brands, Inc.
View source version on accesswire.com:
https://www.accesswire.com/706664/Avant-Brands-Announces-Timing-of-Release-of-Q2-2022-Results-and-Conference-Call
* Efficacy, safety, and cost-effectiveness of Thermobalancing therapy and Dr Allen's Devices were showcased at…
FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…
PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…
Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…
TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…